Pharma Nachrichten

Zeit	Aktuelle Nachrichten Sprache: Alle DE EN	Leser	Medien
23:46	FDA genehmigt neue Jakafi-Formulierung von Incyte mit einmal täglicher Einnahme	2	Investing.com Deutsch
23:42	FDA approves Incyte's once-daily Jakafi XR formulation	4	Investing.com
23:30	Incyte Announces FDA Approval of Jakafi XR (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease	147	Business Wire	Jakafi XR is a once-daily, film-coated, extended-release formulation of Jakafi(ruxolitinib) Once-daily Jakafi XR was shown to provide consistent, day-long exposure comparable to twice-daily... ► Artikel lesen
23:30	Neural Therapeutics Inc: Neural Therapeutics files meeting materials for AGSM	2	Stockwatch
23:22	Fluent verkauft Cannabis-Geschäft in Texas für 30 Millionen US-Dollar	2	Investing.com Deutsch
23:06	FLUENT to sell Texas cannabis operations for $30M	1	Seeking Alpha
23:06	Fluent to sell Texas cannabis operations for $30 million	2	Investing.com
22:54	FLUENT Corp: FLUENT Enters into Definitive Agreement to sell Texas Business	1	GlobeNewswire (USA)
22:36	ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	1	GlobeNewswire (USA)
22:35	Canada approves second generic version of Ozempic	4	Reuters
22:27	Grown Rogue International Inc. - 10-K/A, Annual Report	-	SEC Filings
22:23	REGENTIS BIOMATERIALS LTD. - F-1, Registration statement for certain foreign private issuers	-	SEC Filings
22:18	City View Green Holdings Inc (2): City View Green completes $897,106 shares-for-debt deal	1	Stockwatch
22:18	Curaleaf Holdings Inc: Curaleaf appoints Greif as director	2	Stockwatch
22:10	FDA hands Pfizer, Arvinas' Veppanu early approval for breast cancer subtype	7	FiercePharma
21:58	Tonix Pharmaceuticals Holding Corp. - 8-K, Current Report	5	SEC Filings
21:54	Lilly's oral weight loss pill Foundayo surpasses 5600 scripts in third week	7	Seeking Alpha
21:19	Health Canada approves 2nd generic version of Ozempic - and it's Canadian	15	BNN Bloomberg
20:50	Adaptogenics Health Corp.: Adaptogenics Health Corp. Announces Strategic Review of Health & Wellness Opportunities and Management Changes	1.068	Newsfile	Vancouver, British Columbia--(Newsfile Corp. - May 1, 2026) - Adaptogenics Health Corp. (CSE: ADPT) ("Adaptogenics", the "Company") announces that its board of directors has initiated a strategic... ► Artikel lesen
20:46	Axsome Drug's FDA Approval Unlocks New Opportunity in Alzheimer's Agitation	1	MedCity News

Zeit

Aktuelle Nachrichten

Sprache: Alle DE EN

Leser

Medien

23:46

FDA genehmigt neue Jakafi-Formulierung von Incyte mit einmal täglicher Einnahme

Investing.com Deutsch

23:42

FDA approves Incyte's once-daily Jakafi XR formulation

Investing.com

23:30

Incyte Announces FDA Approval of Jakafi XR (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease

147

Business Wire

Jakafi XR is a once-daily, film-coated, extended-release formulation of Jakafi(ruxolitinib) Once-daily Jakafi XR was shown to provide consistent, day-long exposure comparable to twice-daily...
► Artikel lesen